Glykin

Glykin-500mg Injection

Amikacin

SHAIGAN PHARMACEUTICALS (PVT) LTD.

Drug Identity

Active Ingredient
Amikacin
Drug Class
Aminoglycoside Antibacterials
ATC Code
D06AX12, J01GB06, S01AA21
Status
Essential Medicine

How It Works

Administer IM injection in large mass. Do not mix with other drugs, administer separately.The quantity of infusion solution in IV infusion should be sufficient to infuse amikacin over 1 to 2 hours in infants, and 30-60 min children and adults; at a final concentration not to exceed 5 mg amikacin/ ml.

How to Take It

Dosage information not available for this product.

Safety Alerts

Myasthenia gravis

Important Warnings

To avoid excessive dosage in obese patients, use ideal weight for height to calculate dose and monitor serum amikacin concentration closely
Care must be taken with dosage, caution in conditions characterized by muscular weakness (aminoglycosides may impair neuromuscular transmission)
Ensure adequate hydration
if possible, dehydration should be corrected before starting an aminoglycoside, if possible, parenteral treatment should not exceed 7 days, renal impairment

Side Effects

Auditory damageimpaired neuromuscular transmissionirreversible ototoxicitynephrotoxicitytransient myasthenic syndrome in patients with normal neuromuscular function with large doses given during surgeryvestibular damage. Rare: Antibiotic-associated colitiselectrolyte disturbanceshypocalcaemiahypokalaemiahypomagnesaemia on prolonged therapynauseaperipheral neuropathystomatitisvomitingBlood disorders

Drug Interactions

Furosemide
ethacrynic acid
anaesthetics. Neuro-muscular blocking drugs.

Pregnancy & Lactation

Pregnancy
Contraindicated
Lactation
Contraindicated

Price Intelligence

Rs 249.98
DRAP approved maximum price · per unit · approved 24 Sep, 2025
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
DRAPper unitRs 249.98

Should you consider an alternative?

Other options containing Amikacin, and what they are not.

For pharma professionalsCompany, market and opportunity intelligence

Company

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.